So the examples of European healthcare working well are (somewhat) contingent on price gouging Americans?
>So the examples of European healthcare working well are (somewhat) contingent on price gouging Americans?
It's more related to the development of new healthcare technologies/medicine. Once a drug is developed it's super cheap to produce and distribute. Getting it developed is where $X billion is spent. If the US incentivized global pharmaceutical companies less by allowing for less profit, the drugs we have now would still exist but new development would probably decrease significantly. That said there are most likely solutions to this problem (government research into medicine instead of for-profit etc).